Site Members can sign up for company wide alerts
Lawsuit Overview
March 15, 2022 - An amended complaint was filed. February 1, 2022 - A complaint was filed. February 19, 2021 - An investor in shares of Immunovant, Inc. (NASDAQ: IMVT) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation in connection with c...
You must register (for free) or login to view the entire case.